Ritonavir and ecstasy.
Baker
R
R
Bowers
M
M
D003042:Cocaine / Q000097:blood / Q000493:pharmacokinetics; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D015198:Designer Drugs / Q000009:adverse effects* / Q000493:pharmacokinetics; D004347:Drug Interactions; D015658:HIV Infections / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000493:pharmacokinetics* / Q000627:therapeutic use; D003932:Heroin / Q000097:blood / Q000493:pharmacokinetics; D006801:Humans; D008691:Methadone / Q000097:blood / Q000493:pharmacokinetics; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000009:adverse effects* / Q000097:blood / Q000493:pharmacokinetics; D019438:Ritonavir / Q000493:pharmacokinetics* / Q000627:therapeutic use
D015198:Designer Drugs; D017320:HIV Protease Inhibitors; D003932:Heroin; D003577:Cytochrome P-450 Enzyme System; D003042:Cocaine; D018817:N-Methyl-3,4-methylenedioxyamphetamine; D019438:Ritonavir; D008691:Methadone